WHC is still in active development. Read this to understand our approach.
depiction of KVWDHTXUZHCGIO-UHFFFAOYSA-N.svg
isomerdesign

Olanzapine

Verificar en isomerdesign

pubchem

Olanzapine

Verificar en pubchem

drugmap

Olanzapine

Verificar en drugmap

wiki

Olanzapine

Verificar en wiki

Data

InChI: InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3

Sinónimos: CS-1114,J-006186,SR-01000759343-6, Zyprexa, Olansek,DB00334,NCGC00096077-04,NSC-801187,(E)-2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine,HMS3374L02,KS-1090,ACT03231,olanzapine, 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine,FT-0673219,OLANZAPINE [MI], LY-170053,2-Methyl-10-(4-methyl-piperazin-1-yl)-4H-3-thia-4,9-diaza-benzo[f]azulene,AKOS005566122,NSC754829, Zyprexa Zydis,Olazax,SCHEMBL117695,Olanzapine (Zyprexa),LY170053,Olanzapine (JAN/USP/INN),Olanzapine Glenmark Europe,2-methyl-4-(4-methyl-1-piperazinyl) -10h-thieno[2,3-b][1,5]benzodiazepine,Zyprexa,Zypadhera,MLS001195646,C17H20N4S,HMS2089M04,HMS3393H05,OLANZAPINE [USP MONOGRAPH],Tox21_111556_1,Tox21_111556, Eli Lilly brand of olanzapine,Zyprexa Velotab,Olzapin,O0393,539O061,2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine,SR-01000759343,SBI-0206786.P001,A806453,Oferta,STL388024,HY-14541,2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine,OLANZAPINE COMPONENT OF SYMBYAX,ZINC52957434,NCGC00096077-05,Olanzapine,5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0,3,7]tetradeca-1(10),3(7),5,8,11,13-hexaene, Midax,BCP9001021,MFCD00866702,CHEBI:7735,Zyprexa Zydis,Olanzapin,MLS001165781,10H-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, Symbyax,OLANZAPINE [USAN], LY 170053, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,AB00639907_08,HSDB 8155, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine,AB00639907_09,OLANZAPINE [WHO-DD],NCGC00096077-06,Q201872,NSC_4585,Zalasta,BO164166, Zyprexa Intramuscular, KS-1090, Zydis,2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine,2-Methyl-4-(4-methyl-1-piperazineyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,Olazax Disperzi,DSSTox_RID_77010,NCGC00096077-18,SCHEMBL28763, 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine,OLANZAPINE [JAN],HMS2051H05,Olanzapine Mylan,2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine,HMS2233F24,Olanzapine Teva,CAS-132539-06-1,HMS2093I04,2-Methyl-4-(4-methyl-1-piperazinyl)- 10H-thieno[2,3-b][1,5]benzodiazepine, Zalasta (TN), Olanzapine (OLA),BDBM35254, LY-170052, Olzapin (TN),Midax,C07322,BIDD:PXR0138,US8802672, Olanzapine,olanzapina, Zydis (TN),OLANZAPINE [USP-RS],NSC801187,Zyprexa Intramuscular,NCGC00389791-02,AB00639907-07,OLANZAPINE [ORANGE BOOK],Olanzapine, >=98% (HPLC),DSSTox_GSID_23388, ALKS-7921, Rexapin (TN),5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene,SPECTRUM1505024,Olanzapine Neopharma,HMS3743A09,Olanzapine, European Pharmacopoeia (EP) Reference Standard,LY-170053,SR-01000759343-4,DSSTox_CID_3388,AC-665,Olanzapine for system suitability, European Pharmacopoeia (EP) Reference Standard,CCG-100922,BDBM82479,Olanzapine cipla,2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,OLANZAPINE [INN],ALBB-027265,Olanzapine, Pharmaceutical Secondary Standard; Certified Reference Material,NCGC00096077-01,L000455,SMR000466345, Olanzapina,2-Methyl-4-(4-methylpiperazin-1-yl)-10H- thieno[2,3-b][1,5]benzodiazepin,HMS3884J21,D00454,OLANZAPINE [EP MONOGRAPH], 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine,LYBALVI COMPONENT OLANZAPINE, Olanzapinum,OLANZAPINE [VANDF],Zolafren,2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine,10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, Olanzapine (JAN/USAN/INN),AB00639907-06,OLANZAPINE [MART.],EN300-119499,Olanzapine [USAN:USP:INN:BAN],OLANZAPINE COMPONENT OF LYBALVI,Olanzapine Glenmark, Olanzapine [USAN:INN], Zolafren (TN),DTXSID9023388,2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine,BCP04917,Olanzapine-d8, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material,Olanzapine (LY-170053), Lilly brand of olanzapine,132539-06-1,2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine #,N7U69T4SZR,SW220248-1,CHEBI:94534,HMS3657I15,ALKS-7921,NSC-754829,MLS001424057, Zalasta,Z1521553472,L005958,CHEMBL715,GTPL47,NC00172,CAS_132539-06-1,Olansek,OLANZAPINE [EMA EPAR],HMS3714J03,Lanzac,Olanzapine Teva,LY 170053,2-methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[3,2-c][1,5]benzodiazepine,AMY7709,ZINC3873830,MLS000759457, Zyprexa Velotab,NCGC00096077-03,s2493,SYMBYAX COMPONENT OLANZAPINE,olanzapinum, Zyprexa (TN),STK634338,Olanzapine, United States Pharmacopeia (USP) Reference Standard,Olanzapine solution,Olanzapine apotex,AKOS000282888,Olanzapine 1.0 mg/ml in Acetonitrile,UNII-N7U69T4SZR, 2-methyl-4-(4-methyl-1-piperazinyl)-10 H-thieno[2,3-b ] [1,5]benzodiazepine,BIDD:GT0332,Olanzapine- Bio-X,Olanzapine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material

Estimated data

Solubilidad: -3.703 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 31.3% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.